The eCoin Peripheral Neurostimulator is a leadless implantable tibial nerve neurostimulator indicated to treat urgency urinary incontinence (UUI) in patients intolerant to or having inadequate response to other more conservative treatments or who have undergone a successful trial of percutaneous tibial nerve stimulation (TNS).
Publications
Hayes Publications are available through the Hayes Knowledge Center, a portal to world-class research and unbiased analyses on the clinical, financial, and risk impacts of emerging, controversial, and disruptive healthcare technologies.Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Prescription Digital Therapeutics for Management of Type 2 Diabetes Mellitus
Focus of the Report: This Health Technology Assessment focuses on the use of prescription digital therapeutics (PDTs) for the management of type 2 diabetes mellitus (T2DM) in adults.
Technology Description: PDTs are a mobile technology that offers patients with diabetes mellitus (DM) t…
Eversense Continuous Glucose Monitoring System for Maintaining Glycemic Control in Adults with Diabetes Mellitus
Focus of the Report: This Health Technology Assessment focuses on the use of the Eversense Continuous Glucose Monitoring (CGM) System (Senseonics Inc.). This minimally invasive, implantable CGM device is used to continuously monitor interstitial glucose levels in patients with diabetes mellitus (DM), with the goal of improving glycemic control and long-term outcomes.
CustomFlex ArtificialIris (HumanOptics AG, Clinical Research Consultants Inc.) for Aniridia
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the CustomFlex Artificial Iris (HumanOptics AG) for treatment of aniridia for improvement in function, quality of life, visual acuity, and/or cosmesis.
Absorbable Nasal Implant (Latera, Stryker) for the Treatment of Nasal Valve Collapse
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Latera (Stryker) absorbable nasal implants for treatment of nasal valve collapse (NVC) for relief of nasal airway obstruction.
Interspinous Nonpedicle Fixation Devices for Lumbar Spinal Fusion
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of interspinous process fixation devices (IPFDs) compared with conventional instruments for lumbar spinal fusion (LSF) (e.g., employing pedicle screws, rods, plates) for patient-oriented outcomes, imaging outcomes, and procedur…
Whole Exome/Genome Sequencing for Neuromuscular Disease and Movement Disorders in Adults
This report evaluates the use of whole exome sequencing (WES) or whole genome sequencing (WGS) to inform clinical action and improve patient outcomes in adults > 18 years of age with undefined neurological phenotypes suggestive of neuromuscular disease or movement disorders who have had no definitive diagnosis following standard diagnostic tests.
ClariFix (Arrinex Inc.) for Treatment of Chronic Rhinitis
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ClariFix (Arrinex Inc.) for improvement of symptoms of chronic rhinitis.
iTind (Olympus) for Benign Prostatic Hyperplasia
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of iTind (intraprostatic temporarily implanted nitinol device) (Olympus Group) for relief of lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH).
Prescription Digital Therapeutics for Management of Type 1 Diabetes Mellitus
Focus of the Report: This Health Technology Assessment focuses on the use of prescription digital therapeutics (PDTs) for the management of type 1 diabetes mellitus (T1DM) in adults.
Technology Description: PDTs are a mobile technology that offers patients with diabetes mellitus (DM) t…